GSK3B and Alzheimer disease: Therefore, chronic systemic administration of AM404 at low dose used maybe reverse cognitive deficits via Akt/GSK3β pathway, not dependent on a direct GSK3β inhibitor, CB1, or TRP1 receptor in hyperglycemic 3×Tg-AD mice.